Article
Diosmetin blocks type Ⅰ interferon signaling by metabolic control of phosphatidylethanolamine
2023-02-09
Abstract excerpt
<title>Abstract</title> <p>Type I interferon (IFN-I) is essential in the development of Systemic Lupus Erythematosus (SLE) and many other autoimmune diseases. To explore the metabolic regulations of IFN-I signaling pathway, we conducted a high through-put screening of a small molecule library and identified diosmetin as a potent compound for blocking IFN-I signaling. We showed diosmetin functioned by preventing t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3b61570f-ced1-56cd-8d96-181eaa2ae021
- DOI
- 10.21203/rs.3.rs-2528258/v1
